JBT Corporation Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call Schedule
JBT Corporation Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call Schedule
JBT Corporation (NYSE: JBT) will report fourth quarter and full year 2023 financial results after the market closes on Tuesday, February 20, 2024. A conference call is scheduled for 10:00 a.m. ET on Wednesday, February 21, 2024.
Please register in advance to participate in the conference call: Conference Call Registration
Upon registering for the conference call, participants will receive dial-in information, as well as a unique registrant and conference ID that they will use to access the event.
The call will be simultaneously webcast, for listen-only mode, by accessing the following website: Webcast Registration. The webcast will also be available for replay shortly after the call ends.
This information is also available on JBT’s website https://ir.jbtc.com/events-and-presentations/.
JBT Corporation (NYSE: JBT) is a leading global technology solutions provider to high-value segments of the food & beverage industry. JBT designs, produces, and services sophisticated products and systems for a broad range of end markets, generating roughly one-half of its annual revenue from recurring parts, service, rebuilds, and leasing operations. JBT Corporation employs approximately 5,100 people worldwide and operates sales, service, manufacturing, and sourcing operations in more than 25 countries. For more information, please visit www.jbtc.com.
Investors & Media:
Kedric Meredith
(312) 861-6034
kedric.meredith@jbtc.com
Marlee Spangler
(312) 861-5789
marlee.spangler@jbtc.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20240207291904/en/
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth